NorthWest Biotherapeutics Inc (NWBO)

[KRISGO]

It’s hard to understand how they planned this. First and foremost, approval is critical—once that happens, we’ll be in a very different position. Without approval, dilution continues at the same pace, around 16–20 million shares per month. If approval comes and the price rises, they could pursue private financing at a set price range, reducing the need for ongoing daily dilution.